Smith Rachel 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Smith Rachel
VP of Research and Development
Transactions
- Exercise/Conversion
Common Stock
2017-12-22$0.16/sh+20,748$3,320→ 20,748 total - Tax Payment
Common Stock
2017-12-22$1.48/sh−2,244$3,321→ 18,504 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-22−20,748→ 0 totalExercise: $0.16From: 2008-01-01Exp: 2018-01-01→ Common Stock (20,748 underlying)
Footnotes (2)
- [F1]On December 22, 2017, the Reporting Person exercised, via cashless exercise, stock options for 20,748 shares of Common Stock. The exercise price was $0.16 per share and the exercise was subject to the terms and conditions of a Stock Option Award which was granted on January 1, 2008 under the Company's 2006 Stock Option Plan.
- [F2]Reflects 2,244 shares withheld by the Issuer at the market price of $1.48 per share to fund the cashless exercise of 20,748 options.